Drug repurposing: a systematic approach to evaluate candidate oral neuroprotective interventions for secondary progressive multiple sclerosis.
<h4>Objective</h4>To develop and implement an evidence based framework to select, from drugs already licenced, candidate oral neuroprotective drugs to be tested in secondary progressive multiple sclerosis.<h4>Design</h4>Systematic review of clinical studies of oral putative n...
Saved in:
| Main Authors: | Hanna M Vesterinen, Peter Connick, Cadi M J Irvine, Emily S Sena, Kieren J Egan, Gary G Carmichael, Afiyah Tariq, Sue Pavitt, Jeremy Chataway, Malcolm R Macleod, Siddharthan Chandran |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0117705 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patterns of Cognitive Dysfunction in Progressive MS
by: Peter Connick, et al.
Published: (2013-01-01) -
Literature data-based de novo candidates for drug repurposing
by: Xianglong Liang, et al.
Published: (2025-08-01) -
Repurposing of epalrestat for neuroprotection in parkinson’s disease via activation of the KEAP1/Nrf2 pathway
by: Huafang Jia, et al.
Published: (2025-04-01) -
Integrative genomic and bioinformatic prioritization of drug repurposing candidates for prostate cancer
by: Lalu Muhammad Irham, et al.
Published: (2025-08-01) -
Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis.
by: Christina A Bulman, et al.
Published: (2015-02-01)